Low
₹2,124.40
High
₹2,160.10
| Previous Close | ₹2,140.40 |
|---|---|
| Day's Range | ₹2,124.40 - ₹2,160.10 |
| Open | ₹2,153.40 |
| 52 Week Range | ₹1,603.50 - ₹2,224.90 |
| Volume | 2,35,620 |
| Market Cap | ₹0.03 |
| Trade Value ( ₹ in Lacs) | 5,046.65 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.44 |
| Price/Earning (TTM) | 48.37 |
| TTM EPS (₹) | 44.19 |
| P/E Ratio | 38.29 |
| Book Value(₹) | 8.25 |
| PAT Margin (%) | 16.25 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 26.73 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 37229.2 | 9494.8 |
| Expenses | N/A | N/A |
| PBT | 8771.1 | 1930.3 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 6525.4 | 1456.9 |
| Founded | 1976 |
|---|---|
| Managing Director | Aman Mehta |
| NSE Symbol | JBCHEPHARM |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,074.97 | 1,879.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,485.96 | 6,755.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,124.14 | 4,386.00 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,201.01 | 8,077.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,640.69 | 1,431.55 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,589.46 | 1,336.95 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,966.32 | 2,273.90 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,03,368.09 | 2,507.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,02,190.60 | 1,050.05 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,01,755.41 | 1,011.25 | 835.50 - 835.50 |
No Records Found
J.B. Chemicals & Pharmaceuticals has informed that it enclosed the Postal Ballot Notice sent to the members of the Company today seeking their assent or dissent by remote e-voting on the Ordinary Resolutions pertaining to (i) Appointment of Aman Mehta (DIN: 08174906) as a Director of the Company, (ii) Appointment of Aman Mehta (DIN: 08174906) as Managing Director of the Company; (iii) Appointment of Amal Kelshikar (DIN: 06378987) as a Non‐Executive Non-Independent Director of the Company; (iv) Appointment of Hasmukh Patel (DIN: 11486584) as a Non-Executive Non-Independent Director of the Company; and (v) appointment of Sudhir Menon (DIN: 09502215) as a Non‐Executive Non-Independent Director of the Company. The Company has sent the said Postal Ballot Notice accompanied by an explanatory statement through e-mail on February 20, 2026 to those members of the Company who had registered their e-mail address with the Company or depository participant/depository as on February 13, 2026 (‘cut-off date’). The remote e-voting through e-voting platform of National Securities Depository shall commence on Sunday, February 22, 2026 at 9.00 am (IST) and end on Monday, March 23, 2026 at 5.00 pm (IST). The result of the postal ballot will be declared on or before Wednesday, March 25, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of JB Chemicals & Pharmaceuticals Ltd. is ₹2,140.40 as of 2026-05-15.
The market capitalisation of JB Chemicals & Pharmaceuticals Ltd. is ₹34,313.80 as of 2026-05-15.
The 1-year return of JB Chemicals & Pharmaceuticals Ltd. is 0.00% as of 2026-05-15.
The P/E ratio of JB Chemicals & Pharmaceuticals Ltd. is 38.29 as of 2026-05-17.
The 52-week high and low of JB Chemicals & Pharmaceuticals Ltd. are ₹2,224.90 and ₹1,603.50, respectively, as of 2026-05-15.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.